<DOC>
	<DOCNO>NCT00863954</DOCNO>
	<brief_summary>The purpose study see use device call Resonator , put low electromagnetic field , effect blood glucose A1c level people Type 2 Diabetes .</brief_summary>
	<brief_title>Application Magnetic Fields Adjunctive Treatment Type II Diabetes</brief_title>
	<detailed_description>The purpose pilot study determine whether application magnetic field generate Resonator result statistically significant reduction finger stick blood glucose level , serum glucose hemoglobin A1c level . The study also investigate induced change serum lipid liver function test indirect marker insulin resistance .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Current diagnosis Type II Diabetes Mellitus A1c level upper limit normal Subject currently perform routine finger stick blood sugar test Subject ambulatory None stable medication regimen without significant side effect least 6 month , willingness ability maintain stable medication regimen throughout course study . Hemoglobin A1c level within 0.8 % range patient mean A1c level last two document determination , must within 2 year baseline test date . Willingness test finger stick blood sugar accord protocol . Willingness lab test blood draw perform accord protocol Willingness maintain stable diet activity regimen duration study . Willing able abstain partake nonessential exist new treatment improve serum blood sugar level . Adequate contraceptive measure female subject Male female Any ethnic group Between 21 80 year age Change medical regimen within 6 month prior initiation study Any sign Type I diabetes Active infectious process within 3 week study initiation cause wide fluctuation finger stick blood sugar level . Change BMI great 6 % within 6 month period prior study initiation Any plan revascularization procedure Symptomatic congestive heart failure Leg foot ulceration open wound Gangrene History intermittent claudication Hemodialysis Currently treat malignancy Currently treat oral intravenous catabolic steroid . Reported consumption 14 alcoholic drink per week . Pregnant , breast feeding , plan pregnancy prior end participation . Developmental disability cognitive impairment would make difficult subject partake clinical study , include adequate comprehension inform consent form ability record necessary measurement . Uncontrolled hypertension Uncontrolled atrial fibrillation uncontrolled arrythmias , e.g . tachycardia , bradycardia Uncontrolled seizure disorder Uncontrolled , unstable , untreated medical condition may significantly impact subject health ability complete entire study , opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>